Table 2 Rates of positive BRCA1 and BRCA2 mutations; subgroup analysis.

From: Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan

Variable

Total

Positive Mutations

BRCA1

BRCA2

BRCA1& BRCA2

P-Value*

Age at diagnosis (years)

 ≤ 35

341

16

34

50 (14.7%)

0.017

 > 35

275

9

16

25 (9.1%)

One or more close relative with breast cancer at any age

Yes

305

9

37

46 (15.1%)

0.029

No

311

15

14

29 (9.3%)

One or more close relatives with breast cancer diagnosed at age 50 years or younger

Yes

153

3

24

27 (17.6%)

0.017

No

463

22

26

48 (10.4%)

Diagnosed at ≤ 60 years with triple negative disease

Yes

69

16

7

23 (33.3%)

 < 0.001

No

547

9

43

52 (9.5%)

Any age with at least 2 breast cancer primaries

Yes

48

6

8

14 (29.2%)

 < 0.001

No

568

19

42

61 (10.7%)

Two or more close relatives with breast cancer

Yes

97

5

24

29 (30.0%)

 < 0.001

No

519

20

26

46 (8.9%)

All patients

616

25

50

75 (12.2%)